Dr. Walker, a board certified dermatologist, earned both her medical degree and her Ph.D. from the University of Iowa. Following her degrees, she completed a residency in dermatology and a research fellowship in the Dermatology Branch, National Cancer Institute at the National Institute of Health (NIH).  Throughout her career, Dr. Walker has served in multiple roles in the pharmaceutical and medical device industry.  Most recently she served as the President and Chief Scientific Officer of Brickell Biotech Inc. where she oversaw the research and development, regulatory, compliance, chemistry, and manufacturing efforts for the company’s product portfolio.  Prior to that she was the Chief Medical Officer at Kythera Biopharmaceuticals. While there, she led research efforts focused on the development of novel, first in class pharmaceutical products for dermatologic and aesthetic medicine.  Before Kythera, Dr. Walker was the Chief Medical Officer at Allergan Medical where her primary research efforts catalyzed the development of alternative hyaluronic acid fillers for facial rejuvenation.  When Allergan acquired Inamed in 2006, she was Inamed’s Executive Vice President and Chief Scientific Officer.  While there, she researched biological toxins, dermal filler substances, bariatric devices, and silicone gel filled breast implants.  Dr. Walker started her Industry career at Allergan where she was the VP of the Dermatology Therapeutic Area.  She also served as a clinical faculty member at the University of California Irvine’s department of dermatology.

Most recently, Dr. Walker formed her own drug development consulting company, Walker Consulting.  She is also a practicing dermatologist in Carpinteria, California.  Dr. Walker presently serves as a supervisory board member at Merz pharmaceuticals and is on the board of directors at Forte Biosciences Inc.  Prior, she served on the board of Neothetics, Inc